Navigation Links
VIVUS Resubmits Qnexa NDA to the FDA
Date:10/17/2011

failure to obtain FDA or foreign authority clearances or approval; noncompliance with FDA or foreign regulations; and our dependence on the performance of our collaborative partners. As with any pharmaceutical in development, there are significant risks with development, regulatory approval, and commercialization of new products. There are no guarantees that our response to the FDA's CRL or the results of the retrospective observational study of fetal outcomes in infants born to mothers exposed to topiramate during pregnancy and subsequent meetings and communications will be sufficient to satisfy the FDA's safety concerns, that the FDA will not require us to conduct any additional  prospective studies or retrospective observational studies, or that any product will receive regulatory approval for any indication or prove to be commercially successful. VIVUS does not undertake an obligation to update or revise any forward-looking statements. Investors should read the risk factors set forth in VIVUS' Form 10-K for the year ending December 31, 2010, and periodic reports filed with the Securities and Exchange Commission.CONTACT:   VIVUS, Inc.Investor Relations:The Trout GroupTimothy E. MorrisBrian Korb Chief Financial Officerbkorb@troutgroup.com650-934-5200646-378-2923Media Relations:GolinHarrisSusan Brophysbrophy@golinharris.com312-729-4359
'/>"/>
SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Results From Phase 3 EQUATE Trial of VIVUS Qnexa Highlighted at European Congress on Obesity
2. VIVUS Initiates Open Label Safety Study of Avanafil for Erectile Dysfunction
3. Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting
4. VIVUS Announces Promotion of Peter Tam to President
5. VIVUS to Present at Lazard Capital Markets Healthcare Conference
6. VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity
7. VIVUS to Host Conference Call and Webcast Discussion of Avanafil Phase 3 Results
8. VIVUS Announces Sale of MUSE Assets to Meda
9. FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA®
10. VIVUS Reports Third Quarter and First Nine Months 2010 Financial Results
11. VIVUS to Present at Two Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... , Aug. 27, 2015  A recent study ... Knee Journal, compared the Arthrosurface HemiCAP® Wave implant, ... versus an "onlay" design implant for isolated patellofemoral ... in function and pain scores, none of the ... osteoarthritis (OA). However, 53% of the patients in ...
(Date:8/27/2015)...  Eli Lilly and Company (NYSE: LLY ) ... Thursday, September 17, 2015. Sue Mahony , Ph.D., ... Richard Gaynor , M.D., senior vice president of ... participate in a fireside chat at 3:30 p.m., Eastern ... will be available on the "Webcasts & Presentations" section ...
(Date:8/27/2015)... , Aug. 27, 2015  A mere one in ... Booz Allen Hamilton . A new white paper ... inefficiencies are impeding and disrupting manufacturers, success. ... and Improve Value In Product Development Processes provides ... data and how it affects the product development process ...
Breaking Medicine Technology:Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3Lilly to Participate in Morgan Stanley Global Healthcare Conference 2New White Paper Reveals How Manufacturers Can Improve Product Development Processes 2
(Date:8/28/2015)... ... August 28, 2015 , ... ... accreditation for its adolescent residential, counseling, day treatment and intensive family based services. ... international standards for quality and its pursuit of excellence. As a nonprofit charity ...
(Date:8/28/2015)... ... August 28, 2015 , ... Northridge dentists Dr. Elyson and Dr. ... $199, patients can currently receive a one hour treatment of this teeth whitening option. ... includes a number of unique features that can turn teeth up to nine shades ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... ... which is dedicated to distributing health information technology innovation to transform quality and ... Results of the survey will be de-identified and aggregated before being publicly shared ...
(Date:8/28/2015)... , ... August 28, 2015 , ... ... of the top 5 millionaire dating sites . According to the listings, ... the second best in this category. , A spokesperson of Top5MillionaireDatingSites.com ...
(Date:8/28/2015)... ... 28, 2015 , ... A complimentary webinar offered by healthcare consulting and accounting ... proposal to mandate bundled payments through the Comprehensive Care for Joint Replacement ... Comprehensive Care for Joint Replacement,” takes place at 12 noon EDT on Wednesday, September ...
Breaking Medicine News(10 mins):Health News:West Ridge Academy Awarded CARF Three-Year Accrediation 2Health News:Northridge Dentists Dr. Elyson and Dr. Assili Now Offer a Special Promotion on Zoom Teeth Whitening 2Health News:WEDI's The Sullivan Institute for Healthcare Innovation Releases Gaps in Care Survey 2Health News:Top5MillionaireDatingSites.com Publishes Its First List of Reviews of the Best Millionaire Dating Sites 2Health News:PYA Offers Complimentary CCJR Webina — Game On 2Health News:PYA Offers Complimentary CCJR Webina — Game On 3
... proper placement and anchor ... ... ; LSE: SN) Endoscopy Division today announced the launch of the,BIORAPTOR 2.3 ... The device is featured at Smith & Nephew Endoscopy,s booth,at the American ...
... today proclaimed March 10-14 as Older Pennsylvanians, Nutrition,Awareness Week ... simple,dietary changes can help to improve their health and ... factor in staying healthy, and that,s,especially true for older ... for the percentage of seniors and their care and ...
... Chartis Group, a leading,healthcare advisory services firm, announced ... Karpook and Gregory Maddrey to the position of,Principal. ... advancing their strategic, organizational and operational,performance., "Each ... our clients and our,firm. Greg, James, Matt and ...
... Wounded in Recent Teen and School Shootings, ... gunman Steven Kazmierczak became the 12th shooter in ... documented by international,drug regulatory agencies to cause suicide, ... one antidepressant, "homicidal,ideation." With casualties from school or ...
... Md., March 5 On Saturday, March,29 at 8:00 ... 5K Run/Walk at,Quiet Waters Park in Annapolis to raise ... $20, runners will experience a beautiful 5K,waterfront course complete ... fastest runners. All proceeds from the event go toward ...
... in Your Teeth, VOORHEES, N.J., March 5 ... similar for 2007. Together with the,government,s economic stimulus tax ... pockets of most taxpayers this Spring, it,s a potential,windfall ... But rather than getting away for a week, you ...
Cached Medicine News:Health News:Smith & Nephew Endoscopy's BIORAPTOR(TM) 2.3 PK Suture Anchor Provides Secure Repair for Shoulder, Hip Instability 2Health News:Smith & Nephew Endoscopy's BIORAPTOR(TM) 2.3 PK Suture Anchor Provides Secure Repair for Shoulder, Hip Instability 3Health News:Smith & Nephew Endoscopy's BIORAPTOR(TM) 2.3 PK Suture Anchor Provides Secure Repair for Shoulder, Hip Instability 4Health News:Governor Rendell Proclaims Older Pennsylvanians' Nutrition Awareness Week 2Health News:Governor Rendell Proclaims Older Pennsylvanians' Nutrition Awareness Week 3Health News:The Chartis Group Elects New Partners: Four Healthcare Industry Experts Promoted to Principal 2Health News:The Chartis Group Elects New Partners: Four Healthcare Industry Experts Promoted to Principal 3Health News:New Mini-Documentary Exposes Psychiatric Drugs Turning Kids into Killers 2Health News:New Mini-Documentary Exposes Psychiatric Drugs Turning Kids into Killers 3Health News:Inaugural Bowen Foundation Run/Walk to Fight Autism in Maryland Set for Saturday, March 29 2Health News:Smile When You Get that Refund 2
... screening of factor-V-related APC resistance. The high ... the factor V:Q506 mutation is obtained by ... of V-DEF Plasma bioreagent. The test design ... and homozygous factor V genotypes. It also ...
Inquire...
Inquire...
... valve is enclosed in a ... the valve from being accidentally ... or reclining positions. The valve ... free ensuring uninterrupted flow and ...
Medicine Products: